The regulatory scrutiny for connected medical devices requires a proactive and efficient approach to vulnerability management to transform this potential burden into a competitive advantage.
Join BioT and Medcrypt for a focused session to both explain the regulatory urgency and demonstrate of a practical solution for effective postmarket surveillance -- a solution that aligns with the latest FDA requirements and MDR law, focuses on Firmware and Software Bill of Materials (SBOM) management and secures your entire device lifecycle.
What you will learn:
- FDA and MDR expectations for postmarket cybersecurity
- Practical SBOM ownership across firmware and software
- Vulnerability intake, triage and response
- Live example from device to remediation
Who should attend:
- C-Level Executives (CEO, CTO, COO) looking to reduce compliance risk, lower OpEx, and accelerate time to market through proactive security strategies.
- Head of Product or R&D needing to integrate security and SBOM management into development processes with minimal engineering overhead and friction.
- Regulatory & Quality Leaders focused on meeting FDA & MDR vulnerability management expectations for automated documentation and evidence.
- Technical Teams (Security, DevOps) searching for a platform to simplify end-to-end vulnerability monitoring, prioritization, and patching workflows.
Speaker Bios:
- Axel Wirth – Medical device security expert at Medcrypt with 20 years of global experience in cybersecurity.
- Om Mahida – Medcrypt's Product leader focused on advancing cybersecurity and SBOM solutions.
- Daniel Adler – Co-Founder of BioT, focused on providing regulated cloud infrastructure for medical devices.
- John Miller – Leads BioT growth and customer engagement for the Americas.
This will be a live session, with Q&A. Recording and slides will be sent to registrants.